Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$3.11 - $4.87 $1.25 Million - $1.95 Million
-400,932 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.66 - $7.67 $1.11 Million - $2.33 Million
303,236 Added 310.39%
400,932 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$3.03 - $5.51 $7,050 - $12,821
2,327 Added 2.44%
97,696 $406,000
Q3 2020

Nov 16, 2020

SELL
$2.9 - $4.29 $116,887 - $172,912
-40,306 Reduced 29.71%
95,369 $321,000
Q2 2020

Aug 14, 2020

BUY
$1.99 - $3.64 $269,993 - $493,857
135,675 New
135,675 $426,000

Others Institutions Holding GNPX

About Genprex, Inc.


  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $76.8M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.